4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-25-000102
Options or other derivatives
- Director acquired 37,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scadden David Director | 2025-06-06 | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1749586749.xml…